GlobalPharm (შპს გლობალფარმი)

panel 2026-09-21Ask

separate · GEL, thousands

Line item	2017	2018	2019	2020	2021	2022	2023	2024	CAGR
Total Revenue	55,410	60,687	60,917	60,656	74,810	72,147	70,611	74,077	+4.2%
Total COGS	48,972	46,065	49,115	53,655	66,149	67,059	53,147	57,229	+2.3%
Gross Profit	6,438	14,622	11,802	7,002	8,661	5,088	17,464	16,849	+14.7%
Gross Margin	11.6%	24.1%	19.4%	11.5%	11.6%	7.1%	24.7%	22.7%
Other Operating Income	0	0	13,444	0	0	0	0	0
	1,054	3,902	135,967	5,446	4,947	4,335	4,447	4,725	+23.9%
EBITDA	5,384	10,720	110,721	1,555	3,714	753	13,017	12,124	+12.3%
EBITDA Margin	9.7%	17.7%	181.8%	2.6%	5.0%	1.0%	18.4%	16.4%
Total D&A	625	754	1,414	2,509	1,278	1,496	1,060	932	+5.9%
EBIT / Operating Income	4,759	9,966	112,135	954	2,436	743	11,957	11,192	+13.0%
Total Interest Income	0	0	0	0	0	1,671	0	0
Total Interest Expense	735	666	1,628	3,771	381	0	1,531	2,239	+17.3%
	180	5,036	2,050	5,531	4,821	9,223	342	2,220	nmf
Profit Before Tax	4,204	14,336	115,814	10,255	6,875	10,152	10,084	6,732	+7.0%
Total Income Tax	0	482	373	221	18	61	809	903	+11.0%
Net Profit / (Loss)	3,478	13,621	13,278	10,796	6,592	9,638	9,275	5,301	+6.2%
Net Margin	6.3%	22.4%	21.8%	17.8%	8.8%	13.4%	13.1%	7.2%

GlobalPharm